Journal Guide

Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function. Representing the needs of the broad neuromodulation community, the journal serves as an instrument for the exchange of high quality data, improving results, advancing science, and as a forum for debate and commentary. Neuromodulation covers an ever expanding field including, pain, headache, movement disorders, spasticity, paralysis, psychiatric disorders, epilepsy, sensory deprivation, gastric dysfunction, obesity, and incontinence. As the official journal of the International Neuromodulation Society (INS), it represents the international practice of neuromodulation, a growing, diverse multidisciplinary field responsible for the development and application of devices and techniques to benefit patients by normalizing function and reducing suffering. In-depth reviews, original articles, national and international meeting abstracts, special focus editions, and web-based educational offerings help the reader to expand their knowledge and understanding of the interface between electrical stimulation, chemical neuromodulation, the nervous system and the patient. Neurotechnology reports keep the reader informed of the rapidly changing landscape of the business of neuromodulation, while our updates on past and future news of events and activities of the INS and its membership keep the reader abreast of issues related to professional education and development in this dynamic field.

Neuromorphic Computing and Engineering is a multidisciplinary, open access journal publishing cutting edge research on the design, development and application of artificial neural networks and systems from both a hardware and computational perspective.

This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).The Editors welcome original articles from all areas of the field:• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.• Studies of animal models relevant to the human diseases.The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.In addition to original research papers, the journal also publishes reviews and mini-reviews, preliminary short communications and book reviews, and has editorial, correspondence and news sections. Reports on congresses and workshops, taking the form of a digested or very comprehensive commentary, pointing out some of the particular highlights in relation to the contributors and giving some detail of the area covered, important contributions and a list of participants, are also welcome.The journal is published monthly and aims at rapid publication of high quality papers of scientific merit as well as general interest to a wide readership. There is also a fast track for rapid publication of new material of outstanding scientific merit and importance.Neuromuscular Disorders is the official journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.

For the last fifteen years, Neuron has established itself as one of the most influential and relied upon journals in the field of neuroscience. The editors embrace interdisciplinary strategies which integrate biophysical, cellular, developmental, and molecular approaches with a systems approach to sensory, motor, and higher-order cognitive functions. Neuron serves as one of the premier intellectual forums of the entire neuroscience community.Submitted papers are reviewed for both technical excellence and general interest; those papers that are of general interest for the field as a whole are published within 10 weeks. Neuron also includes minireviews, reviews, and neurotechniques, which keep readers abreast of all developments in neuroscience, as well as announcements for positions available and forthcoming conferences.Visit theNeuron website to find out more - http://www.neuron.org.

The mission of Neuronal Signaling is to provide an interdisciplinary home for neuroscience covering all aspects of in vitro and in vivo signaling from cell to brain in health and disease. Relevant topics range from signaling pathways involved in nervous system development and normal physiology through to neurodegenerative, neurological and psychiatric disorders and other pathologies.
The Journal covers a number of areas of neuroscience, including (but not limited to):

Addiction, affective disorders and depression, aging, cellular and molecular mechanisms of behaviour, cognition, epilepsy, gene therapy, learning and memory, neurodegeneration, neuroendocrinology, neurogenesis, neuroimmunology, neurooncology, neuropharmacology and therapeutics, neurotoxicity, pain and analgesia, psychiatric disorders, stress and fear, stroke and cerebrovascular disease, technical developments and methodologies in neuroscience research.

Neuropathology is an international journal sponsored by the Japanese Society of Neuropathology and publishes peer-reviewed original papers dealing with all aspects of human and experimental neuropathology and related fields of research. The Journal aims to promote the international exchange of results and encourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Short Communications, Occasional Reviews, Editorials and Letters to the Editor. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.

* Neuropathology and Applied Neurobiology is an international journal, sponsored by the British Neuropathological Society, for the publication of original papers and authoritative reviews on the disease mechanisms and the clinical pathology of disorders of brain, nerve and muscle.

For key insights into today's practice of pediatric neurology, Neuropediatrics is the worldwide journal of choice. Original articles, case reports and panel discussions are the distinctive features of a journal that always keeps abreast of current developments and trends. Pediatricians, neurologists, neurosurgeons, and neurobiologists will find it essential reading.

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).Neuropharmacology also publishes succinct topical reviews on subjects within its remit. These reviews (of between 3000 and 5000 words) are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief ahead of time of their intention to submit a review and to indicate clearly how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a decision regarding their proposed review as quickly as possible.The scope of the journal is broad. It covers many disciplines and spans molecules (e.g., molecular biology, biochemistry) through systems (e.g., neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychcopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischaemia, neuroprotection, neurodegeneration, drugs of abuse and pain.The journal publishes occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/ for details of this year's meeting and accompanying Special Issue.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyNeuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Neurophysiology is an international scientific journal. It features a broad, interdisciplinary scope, which covers studies on molecular, cellular, and systemic neurophysiology, functional neuromorphology, neuropharmacology, and neurochemistry. Papers on neuromuscular physiology, neural mechanisms of higher nervous activity and behavior, neurophysiology, medical aspects of neurophysiology, and modeling of neural functions are also accepted. Both original experimental papers and review papers on contemporary problems of neuroscience can be submitted.

Die Zeitschrift ist das offizielle Organ der „Österreichischen Gesellschaft für Psychiatrie und Psychotherapie (ÖGPP)',
und wissenschaftliches Organ der
Österreichischen Alzheimer Gesellschaft, der
Österreichischen Gesellschaft für Kinder- und Jugendpsychiatrie, der
Österreichischen Schizophreniegesellschaft, und der
pro mente austria - Österreichischer Dachverband der Vereine und Gesellschaften für psychische und soziale Gesundheit.Sie veröffentlicht Übersichten zu relevanten Themen des Fachs, Originalarbeiten, Kasuistiken sowie Briefe an die Herausgeber. Zudem wird auch Buchbesprechungen sowie Neuigkeiten aus den Bereichen Personalia, Standes- und Berufspolitik sowie Kongressankündigungen Raum gewidmet.Thematisch ist das Fach Psychiatrie und die Methoden der Psychotherapie in allen ihren Facetten vertreten. Die Zeitschrift richtet sich somit an alle Berufsgruppen, die sich mit Ursachen, Erscheinungsformen und Behandlungsmöglichkeiten von psychischen Störungen beschäftigen. 
 , .

Organ of the 'Société française de psychiatrie de l'enfant et de l'adolescent', Neuropsychiatrie de l'enfance et de l'adolescence tackles all fields of child-adolescent psychiatry and offers a link between field and clinical work.As a reference and training tool for students and practitioners, the journal publishes original papers in child psychiatry as well as book reviews and conference reports.Each issue also offers a calendar of the main events dealing with the speciality.